Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| DANAHER CORP /DE/DHR · Entity 2871 | Director | July 31, 2026 | August 04, 2026 |
| OPKO HEALTH, INC.OPK · Entity 4891 | Director · Vice Chairman and President | May 27, 2025 | May 29, 2025 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
DANAHER CORP /DE/
Report date July 31, 2026 · Filed August 04, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Phantom sharesSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 18,708.915 |
Reported balance
After 2026-07-31 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-07-31 · Grant · Acquired 236.633 · Balance 18,708.915 F1: Under the terms of the Non-Employee Directors Deferred Compensation Plan (the "Plan") established under the Danaher Corporation Omnibus Incentive Plan, the reporting person can defer all or part of the cash director fees they are entitled to receive each quarter. Amounts deferred under the plan (which includes dividend accruals on plan balances and may also include cash director fees) are converted into a particular number of notional shares of Danaher common stock, calculated based on the closing price of Danaher's common stock on the quarterly date such amounts otherwise would have been paid. The price shown in Table II, Column 8 above is the closing price per share of the Danaher common stock as reported on the NYSE on the transaction date noted above. F2: Upon distribution, the phantom shares convert into shares of Danaher common stock on a one-for-one basis. F3: The reporting person is fully vested in all amounts deferred under the Plan. |
Filing footnotes · ownership attribution and instrument terms
F1: Under the terms of the Non-Employee Directors Deferred Compensation Plan (the "Plan") established under the Danaher Corporation Omnibus Incentive Plan, the reporting person can defer all or part of the cash director fees they are entitled to receive each quarter. Amounts deferred under the plan (which includes dividend accruals on plan balances and may also include cash director fees) are converted into a particular number of notional shares of Danaher common stock, calculated based on the closing price of Danaher's common stock on the quarterly date such amounts otherwise would have been paid. The price shown in Table II, Column 8 above is the closing price per share of the Danaher common stock as reported on the NYSE on the transaction date noted above.
F2: Upon distribution, the phantom shares convert into shares of Danaher common stock on a one-for-one basis.
F3: The reporting person is fully vested in all amounts deferred under the Plan.
OPKO HEALTH, INC.
Report date May 27, 2025 · Filed May 29, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $1.31 · Expires 2035-05-26 | Direct | 500,000 |
Reported balance
After 2025-05-27 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2025-05-27 · Grant · Acquired 500,000 · Balance 500,000 F1: This option will vest in four equal annual installments beginning May 27, 2026. |
Filing footnotes · ownership attribution and instrument terms
F1: This option will vest in four equal annual installments beginning May 27, 2026.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| July 31, 2026 Filed Aug 4, 2026 21:01 UTC | DANAHER CORP /DE/ DHR · Entity 2871 | GrantPhantom shares · Derivative | 236.633 | $194.98 Strike: $0.00 | $46,138.70 |
DisclosureSEC source: 0000313616-26-000170 · wk-form4_1785877270.xml · derivative · entry 1 Zerhouni Elias A. · CIK 0001478398 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,708.915 Underlying: Common Stock · 236.633 shares Expires not disclosed F1 · security: Under the terms of the Non-Employee Directors Deferred Compensation Plan (the "Plan") established under the Danaher Corporation Omnibus Incentive Plan, the reporting person can defer all or part of the cash director fees they are entitled to receive each quarter. Amounts deferred under the plan (which includes dividend accruals on plan balances and may also include cash director fees) are converted into a particular number of notional shares of Danaher common stock, calculated based on the closing price of Danaher's common stock on the quarterly date such amounts otherwise would have been paid. The price shown in Table II, Column 8 above is the closing price per share of the Danaher common stock as reported on the NYSE on the transaction date noted above. F2 · derivative.exercise_price: Upon distribution, the phantom shares convert into shares of Danaher common stock on a one-for-one basis. F3 · derivative.exercise_date: The reporting person is fully vested in all amounts deferred under the Plan. F3 · derivative.expiration_date: The reporting person is fully vested in all amounts deferred under the Plan. Read SEC document |
| July 15, 2026 Filed Jul 16, 2026 21:00 UTC | DANAHER CORP /DE/ DHR · Entity 2871 | Exercise / conversionDirector stock option (right to buy) · Derivative | 3,298 | $0.00 Strike: $71.88 | $0.00 |
DisclosureSEC source: 0000313616-26-000157 · wk-form4_1784235642.xml · derivative · entry 4 Zerhouni Elias A. · CIK 0001478398 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,298 shares Expires 2026-07-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 15, 2026 Filed Jul 16, 2026 21:00 UTC | DANAHER CORP /DE/ DHR · Entity 2871 | Tax withholdingCommon Stock | 1,181 | $200.79 | $237,132.99 |
DisclosureSEC source: 0000313616-26-000157 · wk-form4_1784235642.xml · nonDerivative · entry 2 Zerhouni Elias A. · CIK 0001478398 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 45,303.282 Read SEC document |
| July 15, 2026 Filed Jul 16, 2026 21:00 UTC | DANAHER CORP /DE/ DHR · Entity 2871 | Exercise / conversionCommon Stock | 3,298 | $71.88 | $237,060.24 |
DisclosureSEC source: 0000313616-26-000157 · wk-form4_1784235642.xml · nonDerivative · entry 1 Zerhouni Elias A. · CIK 0001478398 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 46,484.282 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 15, 2026 Filed May 19, 2026 21:09 UTC | DANAHER CORP /DE/ DHR · Entity 2871 | GrantDirector stock option (right to buy) · Derivative | 1,699 | $0.00 Strike: $161.91 | $0.00 |
DisclosureSEC source: 0000313616-26-000141 · wk-form4_1779224973.xml · derivative · entry 3 Zerhouni Elias A. · CIK 0001478398 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,699 Underlying: Common Stock · 1,699 shares Expires 2036-05-15 Read SEC document |
| May 15, 2026 Filed May 19, 2026 21:09 UTC | DANAHER CORP /DE/ DHR · Entity 2871 | GrantCommon Stock | 680 | $0.00 | $0.00 |
DisclosureSEC source: 0000313616-26-000141 · wk-form4_1779224973.xml · nonDerivative · entry 1 Zerhouni Elias A. · CIK 0001478398 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 43,186.282 F1 · shares: On the date indicated, Danaher Corporation granted the reporting person restricted stock units (RSUs) in the amount indicated. Since the RSUs are payable solely in common stock, they are being reported in Table I of this Form 4. The RSUs vest on the earlier of the first anniversary of the grant date, or the date of (and immediately prior to) the next annual meeting of Danaher's shareholders following the grant date, but the underlying shares are not issued until the earlier of the director's death or the first day of the seventh month following the director's retirement from the Board. Read SEC document |
| April 24, 2026 Filed Apr 28, 2026 21:00 UTC | DANAHER CORP /DE/ DHR · Entity 2871 | GrantPhantom shares · Derivative | 259.718 | $177.25 Strike: $0.00 | $46,035.02 |
DisclosureSEC source: 0000313616-26-000120 · wk-form4_1777410048.xml · derivative · entry 1 Zerhouni Elias A. · CIK 0001478398 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,472.282 Underlying: Common Stock · 259.718 shares Expires not disclosed F1 · security: Under the terms of the Non-Employee Directors Deferred Compensation Plan (the "Plan") established under the Danaher Corporation 2007 Omnibus Incentive Plan, the reporting person can defer all or part of the cash director fees s/he is entitled to receive each quarter. Amounts deferred under the plan (which includes dividend accruals on plan balances and may also include cash director fees) are converted into a particular number of notional shares of Danaher common stock, calculated based on the closing price of Danaher's common stock on the quarterly date such amounts otherwise would have been paid. The price shown in Table II, Column 8 above is the closing price per share of the Danaher common stock as reported on the NYSE on the transaction date noted above. F2 · derivative.exercise_price: Upon distribution, the phantom shares convert into shares of Danaher common stock on a one-for-one basis. F3 · derivative.exercise_date: The reporting person is fully vested in all amounts deferred under the Plan. F3 · derivative.expiration_date: The reporting person is fully vested in all amounts deferred under the Plan. F1 · derivative.underlying: Under the terms of the Non-Employee Directors Deferred Compensation Plan (the "Plan") established under the Danaher Corporation 2007 Omnibus Incentive Plan, the reporting person can defer all or part of the cash director fees s/he is entitled to receive each quarter. Amounts deferred under the plan (which includes dividend accruals on plan balances and may also include cash director fees) are converted into a particular number of notional shares of Danaher common stock, calculated based on the closing price of Danaher's common stock on the quarterly date such amounts otherwise would have been paid. The price shown in Table II, Column 8 above is the closing price per share of the Danaher common stock as reported on the NYSE on the transaction date noted above. Read SEC document |
| January 30, 2026 Filed Feb 3, 2026 22:26 UTC | DANAHER CORP /DE/ DHR · Entity 2871 | GrantPhantom shares · Derivative | 200.506 | $218.89 Strike: $0.00 | $43,888.76 |
DisclosureSEC source: 0000313616-26-000015 · wk-form4_1770157571.xml · derivative · entry 1 Zerhouni Elias A. · CIK 0001478398 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,212.564 Underlying: Common Stock · 200.506 shares Expires not disclosed F1 · security: Under the terms of the Non-Employee Directors Deferred Compensation Plan (the "Plan") established under the Danaher Corporation 2007 Omnibus Incentive Plan, the reporting person can defer all or part of the cash director fees s/he is entitled to receive each quarter. Amounts deferred under the plan (which includes dividend accruals on plan balances and may also include cash director fees) are converted into a particular number of notional shares of Danaher common stock, calculated based on the closing price of Danaher's common stock on the quarterly date such amounts otherwise would have been paid. The price shown in Table II, Column 8 above is the closing price per share of the Danaher common stock as reported on the NYSE on the transaction date noted above. F2 · derivative.exercise_price: Upon distribution, the phantom shares convert into shares of Danaher common stock on a one-for-one basis. F3 · derivative.exercise_date: The reporting person is fully vested in all amounts deferred under the Plan. F3 · derivative.expiration_date: The reporting person is fully vested in all amounts deferred under the Plan. F1 · derivative.underlying: Under the terms of the Non-Employee Directors Deferred Compensation Plan (the "Plan") established under the Danaher Corporation 2007 Omnibus Incentive Plan, the reporting person can defer all or part of the cash director fees s/he is entitled to receive each quarter. Amounts deferred under the plan (which includes dividend accruals on plan balances and may also include cash director fees) are converted into a particular number of notional shares of Danaher common stock, calculated based on the closing price of Danaher's common stock on the quarterly date such amounts otherwise would have been paid. The price shown in Table II, Column 8 above is the closing price per share of the Danaher common stock as reported on the NYSE on the transaction date noted above. Read SEC document |
| October 31, 2025 Filed Nov 3, 2025 22:01 UTC | DANAHER CORP /DE/ DHR · Entity 2871 | GrantPhantom shares · Derivative | 203.472 | $215.38 Strike: $0.00 | $43,823.80 |
DisclosureSEC source: 0000313616-25-000193 · wk-form4_1762207269.xml · derivative · entry 1 Zerhouni Elias A. · CIK 0001478398 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,012.058 Underlying: Common Stock · 203.472 shares Expires not disclosed F1 · security: Under the terms of the Non-Employee Directors Deferred Compensation Plan (the "Plan") established under the Danaher Corporation 2007 Omnibus Incentive Plan, the reporting person can defer all or part of the cash director fees s/he is entitled to receive each quarter. Amounts deferred under the plan (which includes dividend accruals on plan balances and may also include cash director fees) are converted into a particular number of notional shares of Danaher common stock, calculated based on the closing price of Danaher's common stock on the quarterly date such amounts otherwise would have been paid. The price shown in Table II, Column 8 above is the closing price per share of the Danaher common stock as reported on the NYSE on the transaction date noted above. F2 · derivative.exercise_price: Upon distribution, the phantom shares convert into shares of Danaher common stock on a one-for-one basis. F3 · derivative.exercise_date: The reporting person is fully vested in all amounts deferred under the Plan. F3 · derivative.expiration_date: The reporting person is fully vested in all amounts deferred under the Plan. F1 · derivative.underlying: Under the terms of the Non-Employee Directors Deferred Compensation Plan (the "Plan") established under the Danaher Corporation 2007 Omnibus Incentive Plan, the reporting person can defer all or part of the cash director fees s/he is entitled to receive each quarter. Amounts deferred under the plan (which includes dividend accruals on plan balances and may also include cash director fees) are converted into a particular number of notional shares of Danaher common stock, calculated based on the closing price of Danaher's common stock on the quarterly date such amounts otherwise would have been paid. The price shown in Table II, Column 8 above is the closing price per share of the Danaher common stock as reported on the NYSE on the transaction date noted above. Read SEC document |
| July 25, 2025 Filed Jul 28, 2025 21:07 UTC | DANAHER CORP /DE/ DHR · Entity 2871 | GrantPhantom shares · Derivative | 212.943 | $205.48 Strike: $0.00 | $43,755.53 |
DisclosureSEC source: 0000313616-25-000170 · wk-form4_1753736862.xml · derivative · entry 1 Zerhouni Elias A. · CIK 0001478398 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,808.586 Underlying: Common Stock · 212.943 shares Expires not disclosed F1 · security: Under the terms of the Non-Employee Directors Deferred Compensation Plan (the "Plan") established under the Danaher Corporation 2007 Omnibus Incentive Plan, the reporting person can defer all or part of the cash director fees s/he is entitled to receive each quarter. Amounts deferred under the plan (which includes dividend accruals on plan balances and may also include cash director fees) are converted into a particular number of notional shares of Danaher common stock, calculated based on the closing price of Danaher's common stock on the quarterly date such amounts otherwise would have been paid. The price shown in Table II, Column 8 above is the closing price per share of the Danaher common stock as reported on the NYSE on the transaction date noted above. F2 · derivative.exercise_price: Upon distribution, the phantom shares convert into shares of Danaher common stock on a one-for-one basis. F3 · derivative.exercise_date: The reporting person is fully vested in all amounts deferred under the Plan. F3 · derivative.expiration_date: The reporting person is fully vested in all amounts deferred under the Plan. F1 · derivative.underlying: Under the terms of the Non-Employee Directors Deferred Compensation Plan (the "Plan") established under the Danaher Corporation 2007 Omnibus Incentive Plan, the reporting person can defer all or part of the cash director fees s/he is entitled to receive each quarter. Amounts deferred under the plan (which includes dividend accruals on plan balances and may also include cash director fees) are converted into a particular number of notional shares of Danaher common stock, calculated based on the closing price of Danaher's common stock on the quarterly date such amounts otherwise would have been paid. The price shown in Table II, Column 8 above is the closing price per share of the Danaher common stock as reported on the NYSE on the transaction date noted above. Read SEC document |
| July 15, 2025 Filed Jul 16, 2025 21:01 UTC | DANAHER CORP /DE/ DHR · Entity 2871 | Exercise / conversionDirector stock option (right to buy) · Derivative | 3,928 | $0.00 Strike: $59.34 | $0.00 |
DisclosureSEC source: 0000313616-25-000148 · wk-form4_1752699685.xml · derivative · entry 4 Zerhouni Elias A. · CIK 0001478398 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,928 shares Expires 2025-07-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 15, 2025 Filed Jul 16, 2025 21:01 UTC | DANAHER CORP /DE/ DHR · Entity 2871 | Tax withholdingCommon Stock | 1,209 | $192.86 | $233,167.74 |
DisclosureSEC source: 0000313616-25-000148 · wk-form4_1752699685.xml · nonDerivative · entry 2 Zerhouni Elias A. · CIK 0001478398 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 40,804.643 Read SEC document |
| July 15, 2025 Filed Jul 16, 2025 21:01 UTC | DANAHER CORP /DE/ DHR · Entity 2871 | Exercise / conversionCommon Stock | 3,928 | $59.34 | $233,087.52 |
DisclosureSEC source: 0000313616-25-000148 · wk-form4_1752699685.xml · nonDerivative · entry 1 Zerhouni Elias A. · CIK 0001478398 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 42,013.643 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 27, 2025 Filed May 29, 2025 21:05 UTC | OPKO HEALTH, INC. OPK · Entity 4891 | GrantStock Option (Right to Buy) · Derivative | 500,000 | $0.00 Strike: $1.31 | $0.00 |
DisclosureSEC source: 0000950170-25-079115 · ownership.xml · derivative · entry 1 Zerhouni Elias A. · CIK 0001478398 · Director · Vice Chairman and President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 500,000 Underlying: Common Stock · 500,000 shares Expires 2035-05-26 F1 · derivative.exercise_date: This option will vest in four equal annual installments beginning May 27, 2026. Read SEC document |
| May 15, 2025 Filed May 19, 2025 21:01 UTC | DANAHER CORP /DE/ DHR · Entity 2871 | GrantDirector stock option (right to buy) · Derivative | 1,478 | $0.00 Strike: $190.95 | $0.00 |
DisclosureSEC source: 0000313616-25-000129 · wk-form4_1747688454.xml · derivative · entry 3 Zerhouni Elias A. · CIK 0001478398 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,478 Underlying: Common Stock · 1,478 shares Expires 2035-05-15 Read SEC document |
| May 15, 2025 Filed May 19, 2025 21:01 UTC | DANAHER CORP /DE/ DHR · Entity 2871 | GrantCommon Stock | 577 | $0.00 | $0.00 |
DisclosureSEC source: 0000313616-25-000129 · wk-form4_1747688454.xml · nonDerivative · entry 1 Zerhouni Elias A. · CIK 0001478398 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 38,085.643 F1 · shares: On the date indicated, Danaher Corporation granted the reporting person restricted stock units (RSUs) in the amount indicated. Since the RSUs are payable solely in common stock, they are being reported in Table I of this Form 4. The RSUs vest on the earlier of the first anniversary of the grant date, or the date of (and immediately prior to) the next annual meeting of Danaher's shareholders following the grant date, but the underlying shares are not issued until the earlier of the director's death or the first day of the seventh month following the director's retirement from the Board. Read SEC document |
| April 25, 2025 Filed Apr 29, 2025 21:00 UTC | DANAHER CORP /DE/ DHR · Entity 2871 | GrantPhantom shares · Derivative | 221.592 | $197.14 Strike: $0.00 | $43,684.65 |
DisclosureSEC source: 0000313616-25-000099 · wk-form4_1745960419.xml · derivative · entry 1 Zerhouni Elias A. · CIK 0001478398 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,595.643 Underlying: Common Stock · 221.592 shares Expires not disclosed F1 · security: Under the terms of the Non-Employee Directors Deferred Compensation Plan (the "Plan") established under the Danaher Corporation 2007 Omnibus Incentive Plan, the reporting person can defer all or part of the cash director fees s/he is entitled to receive each quarter. Amounts deferred under the plan (which includes dividend accruals on plan balances and may also include cash director fees) are converted into a particular number of notional shares of Danaher common stock, calculated based on the closing price of Danaher's common stock on the quarterly date such amounts otherwise would have been paid. The price shown in Table II, Column 8 above is the closing price per share of the Danaher common stock as reported on the NYSE on the transaction date noted above. F2 · derivative.exercise_price: Upon distribution, the phantom shares convert into shares of Danaher common stock on a one-for-one basis. F3 · derivative.exercise_date: The reporting person is fully vested in all amounts deferred under the Plan. F3 · derivative.expiration_date: The reporting person is fully vested in all amounts deferred under the Plan. F1 · derivative.underlying: Under the terms of the Non-Employee Directors Deferred Compensation Plan (the "Plan") established under the Danaher Corporation 2007 Omnibus Incentive Plan, the reporting person can defer all or part of the cash director fees s/he is entitled to receive each quarter. Amounts deferred under the plan (which includes dividend accruals on plan balances and may also include cash director fees) are converted into a particular number of notional shares of Danaher common stock, calculated based on the closing price of Danaher's common stock on the quarterly date such amounts otherwise would have been paid. The price shown in Table II, Column 8 above is the closing price per share of the Danaher common stock as reported on the NYSE on the transaction date noted above. Read SEC document |
| January 31, 2025 Filed Feb 4, 2025 22:36 UTC | DANAHER CORP /DE/ DHR · Entity 2871 | GrantPhantom shares · Derivative | 186.386 | $222.74 Strike: $0.00 | $41,515.62 |
DisclosureSEC source: 0000313616-25-000037 · wk-form4_1738708594.xml · derivative · entry 1 Zerhouni Elias A. · CIK 0001478398 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,374.051 Underlying: Common Stock · 186.386 shares Expires not disclosed F1 · security: Under the terms of the Non-Employee Directors Deferred Compensation Plan (the "Plan") established under the Danaher Corporation 2007 Omnibus Incentive Plan, the reporting person can defer all or part of the cash director fees s/he is entitled to receive each quarter. Amounts deferred under the plan (which includes dividend accruals on plan balances and may also include cash director fees) are converted into a particular number of notional shares of Danaher common stock, calculated based on the closing price of Danaher's common stock on the quarterly date such amounts otherwise would have been paid. The price shown in Table II, Column 8 above is the closing price per share of the Danaher common stock as reported on the NYSE on the transaction date noted above. F2 · derivative.exercise_price: Upon distribution, the phantom shares convert into shares of Danaher common stock on a one-for-one basis. F3 · derivative.exercise_date: The reporting person is fully vested in all amounts deferred under the Plan. F3 · derivative.expiration_date: The reporting person is fully vested in all amounts deferred under the Plan. F1 · derivative.underlying: Under the terms of the Non-Employee Directors Deferred Compensation Plan (the "Plan") established under the Danaher Corporation 2007 Omnibus Incentive Plan, the reporting person can defer all or part of the cash director fees s/he is entitled to receive each quarter. Amounts deferred under the plan (which includes dividend accruals on plan balances and may also include cash director fees) are converted into a particular number of notional shares of Danaher common stock, calculated based on the closing price of Danaher's common stock on the quarterly date such amounts otherwise would have been paid. The price shown in Table II, Column 8 above is the closing price per share of the Danaher common stock as reported on the NYSE on the transaction date noted above. Read SEC document |
| October 25, 2024 Filed Oct 28, 2024 21:01 UTC | DANAHER CORP /DE/ DHR · Entity 2871 | GrantPhantom shares · Derivative | 168.996 | $245.39 Strike: $0.00 | $41,469.93 |
DisclosureSEC source: 0000313616-24-000238 · wk-form4_1730149284.xml · derivative · entry 1 Zerhouni Elias A. · CIK 0001478398 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,187.664 Underlying: Common Stock · 168.996 shares Expires not disclosed F1 · security: Under the terms of the Non-Employee Directors Deferred Compensation Plan (the "Plan") established under the Danaher Corporation 2007 Omnibus Incentive Plan, the reporting person can defer all or part of the cash director fees s/he is entitled to receive each quarter. Amounts deferred under the plan (which includes dividend accruals on plan balances and may also include cash director fees) are converted into a particular number of notional shares of Danaher common stock, calculated based on the closing price of Danaher's common stock on the quarterly date such amounts otherwise would have been paid. The price shown in Table II, Column 8 above is the closing price per share of the Danaher common stock as reported on the NYSE on the transaction date noted above. F2 · derivative.exercise_price: Upon distribution, the phantom shares convert into shares of Danaher common stock on a one-for-one basis. F3 · derivative.exercise_date: The reporting person is fully vested in all amounts deferred under the Plan. F3 · derivative.expiration_date: The reporting person is fully vested in all amounts deferred under the Plan. F1 · derivative.underlying: Under the terms of the Non-Employee Directors Deferred Compensation Plan (the "Plan") established under the Danaher Corporation 2007 Omnibus Incentive Plan, the reporting person can defer all or part of the cash director fees s/he is entitled to receive each quarter. Amounts deferred under the plan (which includes dividend accruals on plan balances and may also include cash director fees) are converted into a particular number of notional shares of Danaher common stock, calculated based on the closing price of Danaher's common stock on the quarterly date such amounts otherwise would have been paid. The price shown in Table II, Column 8 above is the closing price per share of the Danaher common stock as reported on the NYSE on the transaction date noted above. Read SEC document |
| July 26, 2024 Filed Jul 29, 2024 21:00 UTC | DANAHER CORP /DE/ DHR · Entity 2871 | GrantPhantom shares · Derivative | 151.251 | $273.19 Strike: $0.00 | $41,320.26 |
DisclosureSEC source: 0000313616-24-000201 · wk-form4_1722286812.xml · derivative · entry 1 Zerhouni Elias A. · CIK 0001478398 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,018.668 Underlying: Common Stock · 151.251 shares Expires not disclosed F1 · security: Under the terms of the Non-Employee Directors Deferred Compensation Plan (the "Plan") established under the Danaher Corporation 2007 Omnibus Incentive Plan, the reporting person can defer all or part of the cash director fees s/he is entitled to receive each quarter. Amounts deferred under the plan (which includes dividend accruals on plan balances and may also include cash director fees) are converted into a particular number of notional shares of Danaher common stock, calculated based on the closing price of Danaher's common stock on the quarterly date such amounts otherwise would have been paid. The price shown in Table II, Column 8 above is the closing price per share of the Danaher common stock as reported on the NYSE on the transaction date noted above. F2 · derivative.exercise_price: Upon distribution, the phantom shares convert into shares of Danaher common stock on a one-for-one basis. F3 · derivative.exercise_date: The reporting person is fully vested in all amounts deferred under the Plan. F3 · derivative.expiration_date: The reporting person is fully vested in all amounts deferred under the Plan. F1 · derivative.underlying: Under the terms of the Non-Employee Directors Deferred Compensation Plan (the "Plan") established under the Danaher Corporation 2007 Omnibus Incentive Plan, the reporting person can defer all or part of the cash director fees s/he is entitled to receive each quarter. Amounts deferred under the plan (which includes dividend accruals on plan balances and may also include cash director fees) are converted into a particular number of notional shares of Danaher common stock, calculated based on the closing price of Danaher's common stock on the quarterly date such amounts otherwise would have been paid. The price shown in Table II, Column 8 above is the closing price per share of the Danaher common stock as reported on the NYSE on the transaction date noted above. Read SEC document |
| July 24, 2024 Filed Jul 26, 2024 23:08 UTC | OPKO HEALTH, INC. OPK · Entity 4891 | GrantCommon Stock | 500,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-087032 · ownership.xml · nonDerivative · entry 1 Zerhouni Elias A. · CIK 0001478398 · Director · Vice Chairman and President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 589,600 F1 · security: Each restricted stock unit represents a contingent right to receive one share of OPKO common stock upon the vesting of the award. The restricted stock units vest 50% on the second anniversary of the grant date, then 25% on each of the following two years. Read SEC document |
| July 15, 2024 Filed Jul 16, 2024 21:01 UTC | DANAHER CORP /DE/ DHR · Entity 2871 | Exercise / conversionDirector stock option (right to buy) · Derivative | 3,289 | $0.00 Strike: $52.56 | $0.00 |
DisclosureSEC source: 0000313616-24-000184 · wk-form4_1721163667.xml · derivative · entry 4 Zerhouni Elias A. · CIK 0001478398 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,289 shares Expires 2024-07-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 15, 2024 Filed Jul 16, 2024 21:01 UTC | DANAHER CORP /DE/ DHR · Entity 2871 | Tax withholdingCommon Stock | 703 | $246.23 | $173,099.69 |
DisclosureSEC source: 0000313616-24-000184 · wk-form4_1721163667.xml · nonDerivative · entry 2 Zerhouni Elias A. · CIK 0001478398 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 36,780.417 Read SEC document |
| July 15, 2024 Filed Jul 16, 2024 21:01 UTC | DANAHER CORP /DE/ DHR · Entity 2871 | Exercise / conversionCommon Stock | 3,289 | $52.56 | $172,869.84 |
DisclosureSEC source: 0000313616-24-000184 · wk-form4_1721163667.xml · nonDerivative · entry 1 Zerhouni Elias A. · CIK 0001478398 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 37,483.417 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 15, 2024 Filed May 17, 2024 21:02 UTC | DANAHER CORP /DE/ DHR · Entity 2871 | GrantDirector stock option (right to buy) · Derivative | 1,081 | $0.00 Strike: $263.46 | $0.00 |
DisclosureSEC source: 0000313616-24-000158 · wk-form4_1715979692.xml · derivative · entry 3 Zerhouni Elias A. · CIK 0001478398 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,081 Underlying: Common Stock · 1,081 shares Expires 2034-05-15 Read SEC document |
| May 15, 2024 Filed May 17, 2024 21:02 UTC | DANAHER CORP /DE/ DHR · Entity 2871 | GrantCommon Stock | 390 | $0.00 | $0.00 |
DisclosureSEC source: 0000313616-24-000158 · wk-form4_1715979692.xml · nonDerivative · entry 1 Zerhouni Elias A. · CIK 0001478398 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 34,194.417 F1 · shares: On the date indicated, Danaher Corporation granted the reporting person restricted stock units (RSUs) in the amount indicated. Since the RSUs are payable solely in common stock, they are being reported in Table I of this Form 4. The RSUs vest on the earlier of the first anniversary of the grant date, or the date of (and immediately prior to) the next annual meeting of Danaher's shareholders following the grant date, but the underlying shares are not issued until the earlier of the director's death or the first day of the seventh month following the director's retirement from the Board. Read SEC document |
| April 26, 2024 Filed Apr 29, 2024 21:01 UTC | DANAHER CORP /DE/ DHR · Entity 2871 | GrantPhantom shares · Derivative | 167.832 | $246.58 Strike: $0.00 | $41,384.01 |
DisclosureSEC source: 0000313616-24-000126 · wk-form4_1714424504.xml · derivative · entry 1 Zerhouni Elias A. · CIK 0001478398 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,867.417 Underlying: Common Stock · 167.832 shares Expires not disclosed F1 · security: Under the terms of the Non-Employee Directors Deferred Compensation Plan (the "Plan") established under the Danaher Corporation 2007 Omnibus Incentive Plan, the reporting person can defer all or part of the cash director fees s/he is entitled to receive each quarter. Amounts deferred under the plan (which includes dividend accruals on plan balances and may also include cash director fees) are converted into a particular number of notional shares of Danaher common stock, calculated based on the closing price of Danaher's common stock on the quarterly date such amounts otherwise would have been paid. The price shown in Table II, Column 8 above is the closing price per share of the Danaher common stock as reported on the NYSE on the transaction date noted above. F2 · derivative.exercise_price: Upon distribution, the phantom shares convert into shares of Danaher common stock on a one-for-one basis. F3 · derivative.exercise_date: The reporting person is fully vested in all amounts deferred under the Plan. F3 · derivative.expiration_date: The reporting person is fully vested in all amounts deferred under the Plan. F1 · derivative.underlying: Under the terms of the Non-Employee Directors Deferred Compensation Plan (the "Plan") established under the Danaher Corporation 2007 Omnibus Incentive Plan, the reporting person can defer all or part of the cash director fees s/he is entitled to receive each quarter. Amounts deferred under the plan (which includes dividend accruals on plan balances and may also include cash director fees) are converted into a particular number of notional shares of Danaher common stock, calculated based on the closing price of Danaher's common stock on the quarterly date such amounts otherwise would have been paid. The price shown in Table II, Column 8 above is the closing price per share of the Danaher common stock as reported on the NYSE on the transaction date noted above. Read SEC document |
| January 26, 2024 Filed Jan 30, 2024 22:05 UTC | DANAHER CORP /DE/ DHR · Entity 2871 | GrantPhantom shares · Derivative | 172.603 | $233.00 Strike: $0.00 | $40,216.50 |
DisclosureSEC source: 0000313616-24-000015 · wk-form4_1706652292.xml · derivative · entry 1 Zerhouni Elias A. · CIK 0001478398 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,699.585 Underlying: Common Stock · 172.603 shares Expires not disclosed F1 · security: Under the terms of the Non-Employee Directors Deferred Compensation Plan (the "Plan") established under the Danaher Corporation 2007 Omnibus Incentive Plan, the reporting person can defer all or part of the cash director fees s/he is entitled to receive each quarter. Amounts deferred under the plan (which includes dividend accruals on plan balances and may also include cash director fees) are converted into a particular number of notional shares of Danaher common stock, calculated based on the closing price of Danaher's common stock on the quarterly date such amounts otherwise would have been paid. The price shown in Table II, Column 8 above is the closing price per share of the Danaher common stock as reported on the NYSE on the transaction date noted above. F2 · derivative.exercise_price: Upon distribution, the phantom shares convert into shares of Danaher common stock on a one-for-one basis. F3 · derivative.exercise_date: The reporting person is fully vested in all amounts deferred under the Plan. F3 · derivative.expiration_date: The reporting person is fully vested in all amounts deferred under the Plan. F1 · derivative.underlying: Under the terms of the Non-Employee Directors Deferred Compensation Plan (the "Plan") established under the Danaher Corporation 2007 Omnibus Incentive Plan, the reporting person can defer all or part of the cash director fees s/he is entitled to receive each quarter. Amounts deferred under the plan (which includes dividend accruals on plan balances and may also include cash director fees) are converted into a particular number of notional shares of Danaher common stock, calculated based on the closing price of Danaher's common stock on the quarterly date such amounts otherwise would have been paid. The price shown in Table II, Column 8 above is the closing price per share of the Danaher common stock as reported on the NYSE on the transaction date noted above. Read SEC document |
| January 05, 2024 Filed Jan 5, 2024 22:26 UTC | OPKO HEALTH, INC. OPK · Entity 4891 | PurchaseCommon Stock | 400,000 | $0.94 | $376,000.00 |
DisclosureSEC source: 0000950170-24-002542 · ownership.xml · nonDerivative · entry 4 Zerhouni Elias A. · CIK 0001478398 · Director · Vice Chairman and President 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnote Disclosed balance after: 20,327,814 F1 · ownership.nature: Shares held by the ZERHOUNI IRREVOCABLE TRUST for the benefit of the Reporting Person and his children and remoter issue, as well as certain qualifying charitable organizations, and for which an independent trustee has been appointed. The independent trustee has delegated investment authority of the trust to the Reporting Person. The Reporting Person disclaims beneficial ownership of these securities, except to the extent of any pecuniary interest therein and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Read SEC document |
| January 05, 2024 Filed Jan 5, 2024 22:26 UTC | OPKO HEALTH, INC. OPK · Entity 4891 | PurchaseCommon Stock | 100,000 | $0.93 | $93,000.00 |
DisclosureSEC source: 0000950170-24-002542 · ownership.xml · nonDerivative · entry 3 Zerhouni Elias A. · CIK 0001478398 · Director · Vice Chairman and President 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnote Disclosed balance after: 19,927,814 F1 · ownership.nature: Shares held by the ZERHOUNI IRREVOCABLE TRUST for the benefit of the Reporting Person and his children and remoter issue, as well as certain qualifying charitable organizations, and for which an independent trustee has been appointed. The independent trustee has delegated investment authority of the trust to the Reporting Person. The Reporting Person disclaims beneficial ownership of these securities, except to the extent of any pecuniary interest therein and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Read SEC document |
| January 05, 2024 Filed Jan 5, 2024 22:26 UTC | OPKO HEALTH, INC. OPK · Entity 4891 | PurchaseCommon Stock | 33,300 | $0.91 | $30,303.00 |
DisclosureSEC source: 0000950170-24-002542 · ownership.xml · nonDerivative · entry 2 Zerhouni Elias A. · CIK 0001478398 · Director · Vice Chairman and President 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnote Disclosed balance after: 19,827,814 F1 · ownership.nature: Shares held by the ZERHOUNI IRREVOCABLE TRUST for the benefit of the Reporting Person and his children and remoter issue, as well as certain qualifying charitable organizations, and for which an independent trustee has been appointed. The independent trustee has delegated investment authority of the trust to the Reporting Person. The Reporting Person disclaims beneficial ownership of these securities, except to the extent of any pecuniary interest therein and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Read SEC document |
| January 05, 2024 Filed Jan 5, 2024 22:26 UTC | OPKO HEALTH, INC. OPK · Entity 4891 | PurchaseCommon Stock | 17,000 | $0.87 | $14,790.00 |
DisclosureSEC source: 0000950170-24-002542 · ownership.xml · nonDerivative · entry 1 Zerhouni Elias A. · CIK 0001478398 · Director · Vice Chairman and President 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnote Disclosed balance after: 19,794,514 F1 · ownership.nature: Shares held by the ZERHOUNI IRREVOCABLE TRUST for the benefit of the Reporting Person and his children and remoter issue, as well as certain qualifying charitable organizations, and for which an independent trustee has been appointed. The independent trustee has delegated investment authority of the trust to the Reporting Person. The Reporting Person disclaims beneficial ownership of these securities, except to the extent of any pecuniary interest therein and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Read SEC document |
| October 27, 2023 Filed Oct 30, 2023 21:02 UTC | DANAHER CORP /DE/ DHR · Entity 2871 | GrantPhantom shares · Derivative | 216.382 | $187.88 Strike: $0.00 | $40,653.85 |
DisclosureSEC source: 0000313616-23-000273 · wk-form4_1698699762.xml · derivative · entry 1 Zerhouni Elias A. · CIK 0001478398 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,526.982 Underlying: Common Stock · 216.382 shares Expires not disclosed F1 · security: Under the terms of the Non-Employee Directors Deferred Compensation Plan (the "Plan") established under the Danaher Corporation 2007 Omnibus Incentive Plan, the reporting person can defer all or part of the cash director fees s/he is entitled to receive each quarter. Amounts deferred under the plan (which includes dividend accruals on plan balances and may also include cash director fees) are converted into a particular number of notional shares of Danaher common stock, calculated based on the closing price of Danaher's common stock on the quarterly date such amounts otherwise would have been paid. The price shown in Table II, Column 8 above is the closing price per share of the Danaher common stock as reported on the NYSE on the transaction date noted above. F2 · derivative.exercise_price: Upon distribution, the phantom shares convert into shares of Danaher common stock on a one-for-one basis. F3 · derivative.exercise_date: The reporting person is fully vested in all amounts deferred under the Plan. F3 · derivative.expiration_date: The reporting person is fully vested in all amounts deferred under the Plan. F1 · derivative.underlying: Under the terms of the Non-Employee Directors Deferred Compensation Plan (the "Plan") established under the Danaher Corporation 2007 Omnibus Incentive Plan, the reporting person can defer all or part of the cash director fees s/he is entitled to receive each quarter. Amounts deferred under the plan (which includes dividend accruals on plan balances and may also include cash director fees) are converted into a particular number of notional shares of Danaher common stock, calculated based on the closing price of Danaher's common stock on the quarterly date such amounts otherwise would have been paid. The price shown in Table II, Column 8 above is the closing price per share of the Danaher common stock as reported on the NYSE on the transaction date noted above. Read SEC document |
| July 28, 2023 Filed Aug 1, 2023 21:02 UTC | DANAHER CORP /DE/ DHR · Entity 2871 | Exercise / conversionDirector stock option (right to buy) · Derivative | 3,490 | $0.00 Strike: $50.80 | $0.00 |
DisclosureSEC source: 0000313616-23-000236 · wk-form4_1690923770.xml · derivative · entry 5 Zerhouni Elias A. · CIK 0001478398 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,490 shares Expires 2023-07-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 28, 2023 Filed Aug 1, 2023 21:02 UTC | DANAHER CORP /DE/ DHR · Entity 2871 | GrantPhantom shares · Derivative | 154.267 | $260.07 Strike: $0.00 | $40,120.22 |
DisclosureSEC source: 0000313616-23-000236 · wk-form4_1690923770.xml · derivative · entry 4 Zerhouni Elias A. · CIK 0001478398 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,488.269 Underlying: Common Stock · 154.267 shares Expires not disclosed F1 · security: Under the terms of the Non-Employee Directors Deferred Compensation Plan (the "Plan") established under the Danaher Corporation 2007 Omnibus Incentive Plan, the reporting person can defer all or part of the cash director fees s/he is entitled to receive each quarter. Amounts deferred under the plan (which includes dividend accruals on plan balances and may also include cash director fees) are converted into a particular number of notional shares of Danaher common stock, calculated based on the closing price of Danaher's common stock on the quarterly date such amounts otherwise would have been paid. The price shown in Table II, Column 8 above is the closing price per share of the Danaher common stock as reported on the NYSE on the transaction date noted above. F2 · derivative.exercise_price: Upon distribution, the phantom shares convert into shares of Danaher common stock on a one-for-one basis. F3 · derivative.exercise_date: The reporting person is fully vested in all amounts deferred under the Plan. F3 · derivative.expiration_date: The reporting person is fully vested in all amounts deferred under the Plan. F1 · derivative.underlying: Under the terms of the Non-Employee Directors Deferred Compensation Plan (the "Plan") established under the Danaher Corporation 2007 Omnibus Incentive Plan, the reporting person can defer all or part of the cash director fees s/he is entitled to receive each quarter. Amounts deferred under the plan (which includes dividend accruals on plan balances and may also include cash director fees) are converted into a particular number of notional shares of Danaher common stock, calculated based on the closing price of Danaher's common stock on the quarterly date such amounts otherwise would have been paid. The price shown in Table II, Column 8 above is the closing price per share of the Danaher common stock as reported on the NYSE on the transaction date noted above. Read SEC document |
| July 28, 2023 Filed Aug 1, 2023 21:02 UTC | DANAHER CORP /DE/ DHR · Entity 2871 | Tax withholdingCommon Stock | 682 | $260.07 | $177,367.74 |
DisclosureSEC source: 0000313616-23-000236 · wk-form4_1690923770.xml · nonDerivative · entry 2 Zerhouni Elias A. · CIK 0001478398 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 29,841.269 Read SEC document |
| July 28, 2023 Filed Aug 1, 2023 21:02 UTC | DANAHER CORP /DE/ DHR · Entity 2871 | Exercise / conversionCommon Stock | 3,490 | $50.80 | $177,292.00 |
DisclosureSEC source: 0000313616-23-000236 · wk-form4_1690923770.xml · nonDerivative · entry 1 Zerhouni Elias A. · CIK 0001478398 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,523.269 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 18, 2023 Filed May 19, 2023 20:38 UTC | OPKO HEALTH, INC. OPK · Entity 4891 | GrantStock Option (Right to Buy) · Derivative | 800,000 | $0.00 Strike: $1.58 | $0.00 |
DisclosureSEC source: 0001209191-23-031035 · doc4.xml · derivative · entry 1 Zerhouni Elias A. · CIK 0001478398 · Director · Vice Chairman and President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 800,000 Underlying: Common Stock · 800,000 shares Expires 2033-05-17 F1 · derivative.exercise_date: This option will vest in four equal annual installments beginning May 18, 2024. Read SEC document |
| May 15, 2023 Filed May 17, 2023 21:05 UTC | DANAHER CORP /DE/ DHR · Entity 2871 | GrantDirector stock option (right to buy) · Derivative | 1,194 | $0.00 Strike: $226.94 | $0.00 |
DisclosureSEC source: 0000313616-23-000205 · wk-form4_1684357532.xml · derivative · entry 3 Zerhouni Elias A. · CIK 0001478398 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,194 Underlying: Common Stock · 1,194 shares Expires 2033-05-15 Read SEC document |
| May 15, 2023 Filed May 17, 2023 21:05 UTC | DANAHER CORP /DE/ DHR · Entity 2871 | GrantCommon Stock | 430 | $0.00 | $0.00 |
DisclosureSEC source: 0000313616-23-000205 · wk-form4_1684357532.xml · nonDerivative · entry 1 Zerhouni Elias A. · CIK 0001478398 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,879.002 F1 · shares: On the date indicated, Danaher Corporation granted the reporting person restricted stock units (RSUs) in the amount indicated. Since the RSUs are payable solely in common stock, they are being reported in Table I of this Form 4. The RSUs vest on the earlier of the first anniversary of the grant date, or the date of (and immediately prior to) the next annual meeting of Danaher's shareholders following the grant date, but the underlying shares are not issued until the earlier of the director's death or the first day of the seventh month following the director's retirement from the Board. Read SEC document |
| April 28, 2023 Filed May 1, 2023 21:07 UTC | DANAHER CORP /DE/ DHR · Entity 2871 | GrantPhantom shares · Derivative | 169.155 | $236.91 Strike: $0.00 | $40,074.51 |
DisclosureSEC source: 0000313616-23-000165 · wf-form4_168297524283210.xml · derivative · entry 1 Zerhouni Elias A. · CIK 0001478398 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,334.002 Underlying: Common Stock · 169.155 shares Expires not disclosed F1 · security: Under the terms of the Non-Employee Directors Deferred Compensation Plan (the "Plan") established under the Danaher Corporation 2007 Omnibus Incentive Plan, the reporting person can defer all or part of the cash director fees s/he is entitled to receive each quarter. Amounts deferred under the plan (which includes dividend accruals on plan balances and may also include cash director fees) are converted into a particular number of notional shares of Danaher common stock, calculated based on the closing price of Danaher's common stock on the quarterly date such amounts otherwise would have been paid. The price shown in Table II, Column 8 above is the closing price per share of the Danaher common stock as reported on the NYSE on the transaction date noted above. F2 · derivative.exercise_price: Upon distribution, the phantom shares convert into shares of Danaher common stock on a one-for-one basis. F3 · derivative.exercise_date: The reporting person is fully vested in all amounts deferred under the Plan. F3 · derivative.expiration_date: The reporting person is fully vested in all amounts deferred under the Plan. F1 · derivative.underlying: Under the terms of the Non-Employee Directors Deferred Compensation Plan (the "Plan") established under the Danaher Corporation 2007 Omnibus Incentive Plan, the reporting person can defer all or part of the cash director fees s/he is entitled to receive each quarter. Amounts deferred under the plan (which includes dividend accruals on plan balances and may also include cash director fees) are converted into a particular number of notional shares of Danaher common stock, calculated based on the closing price of Danaher's common stock on the quarterly date such amounts otherwise would have been paid. The price shown in Table II, Column 8 above is the closing price per share of the Danaher common stock as reported on the NYSE on the transaction date noted above. Read SEC document |
| January 27, 2023 Filed Jan 30, 2023 22:08 UTC | DANAHER CORP /DE/ DHR · Entity 2871 | GrantPhantom shares · Derivative | 149.462 | $265.98 Strike: $0.00 | $39,753.90 |
DisclosureSEC source: 0000313616-23-000044 · wf-form4_167511651253709.xml · derivative · entry 1 Zerhouni Elias A. · CIK 0001478398 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,164.847 Underlying: Common Stock · 149.462 shares Expires not disclosed F1 · security: Under the terms of the Non-Employee Directors Deferred Compensation Plan (the "Plan") established under the Danaher Corporation 2007 Omnibus Incentive Plan, the reporting person can defer all or part of the cash director fees s/he is entitled to receive each quarter. Amounts deferred under the plan (which includes dividend accruals on plan balances and may also include cash director fees) are converted into a particular number of notional shares of Danaher common stock, calculated based on the closing price of Danaher's common stock on the quarterly date such amounts otherwise would have been paid. The price shown in Table II, Column 8 above is the closing price per share of the Danaher common stock as reported on the NYSE on the transaction date noted above. F2 · derivative.exercise_price: Upon distribution, the phantom shares convert into shares of Danaher common stock on a one-for-one basis. F3 · derivative.exercise_date: The reporting person is fully vested in all amounts deferred under the Plan. F3 · derivative.expiration_date: The reporting person is fully vested in all amounts deferred under the Plan. F1 · derivative.underlying: Under the terms of the Non-Employee Directors Deferred Compensation Plan (the "Plan") established under the Danaher Corporation 2007 Omnibus Incentive Plan, the reporting person can defer all or part of the cash director fees s/he is entitled to receive each quarter. Amounts deferred under the plan (which includes dividend accruals on plan balances and may also include cash director fees) are converted into a particular number of notional shares of Danaher common stock, calculated based on the closing price of Danaher's common stock on the quarterly date such amounts otherwise would have been paid. The price shown in Table II, Column 8 above is the closing price per share of the Danaher common stock as reported on the NYSE on the transaction date noted above. Read SEC document |
| October 28, 2022 Filed Oct 31, 2022 21:08 UTC | DANAHER CORP /DE/ DHR · Entity 2871 | GrantPhantom shares · Derivative | 157.722 | $251.80 Strike: $0.00 | $39,714.40 |
DisclosureSEC source: 0000313616-22-000265 · wf-form4_166725048666290.xml · derivative · entry 1 Zerhouni Elias A. · CIK 0001478398 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,015.385 Underlying: Common Stock · 157.722 shares Expires not disclosed F1 · security: Under the terms of the Non-Employee Directors Deferred Compensation Plan (the "Plan") established under the Danaher Corporation 2007 Omnibus Incentive Plan, the reporting person can defer all or part of the cash director fees s/he is entitled to receive each quarter. Amounts deferred under the plan (which includes dividend accruals on plan balances and may also include cash director fees) are converted into a particular number of notional shares of Danaher common stock, calculated based on the closing price of Danaher's common stock on the quarterly date such amounts otherwise would have been paid. The price shown in Table II, Column 8 above is the closing price per share of the Danaher common stock as reported on the NYSE on the transaction date noted above. F2 · derivative.exercise_price: Upon distribution, the phantom shares convert into shares of Danaher common stock on a one-for-one basis. F3 · derivative.exercise_date: The reporting person is fully vested in all amounts deferred under the Plan. F3 · derivative.expiration_date: The reporting person is fully vested in all amounts deferred under the Plan. F1 · derivative.underlying: Under the terms of the Non-Employee Directors Deferred Compensation Plan (the "Plan") established under the Danaher Corporation 2007 Omnibus Incentive Plan, the reporting person can defer all or part of the cash director fees s/he is entitled to receive each quarter. Amounts deferred under the plan (which includes dividend accruals on plan balances and may also include cash director fees) are converted into a particular number of notional shares of Danaher common stock, calculated based on the closing price of Danaher's common stock on the quarterly date such amounts otherwise would have been paid. The price shown in Table II, Column 8 above is the closing price per share of the Danaher common stock as reported on the NYSE on the transaction date noted above. Read SEC document |
| July 29, 2022 Filed Aug 2, 2022 21:12 UTC | DANAHER CORP /DE/ DHR · Entity 2871 | GrantPhantom shares · Derivative | 136.139 | $291.47 Strike: $0.00 | $39,680.43 |
DisclosureSEC source: 0000313616-22-000213 · wf-form4_165947472062369.xml · derivative · entry 1 Zerhouni Elias A. · CIK 0001478398 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,857.663 Underlying: Common Stock · 136.139 shares Expires not disclosed F1 · security: Under the terms of the Non-Employee Directors Deferred Compensation Plan (the "Plan") established under the Danaher Corporation 2007 Omnibus Incentive Plan, the reporting person can defer all or part of the cash director fees he is entitled to receive each quarter. Amounts deferred under the plan (which includes dividend accruals on plan balances and may also include cash director fees) are converted into a particular number of notional shares of Danaher common stock, calculated based on the closing price of Danaher's common stock on the quarterly date such amounts otherwise would have been paid. The price shown in Table II, Column 8 above is the closing price per share of the Danaher common stock as reported on the NYSE on the transaction date noted above. F2 · derivative.exercise_price: Upon distribution, the phantom shares convert into shares of Danaher common stock on a one-for-one basis. F3 · derivative.exercise_date: The reporting person is fully vested in all amounts deferred under the Plan. F3 · derivative.expiration_date: The reporting person is fully vested in all amounts deferred under the Plan. F1 · derivative.underlying: Under the terms of the Non-Employee Directors Deferred Compensation Plan (the "Plan") established under the Danaher Corporation 2007 Omnibus Incentive Plan, the reporting person can defer all or part of the cash director fees he is entitled to receive each quarter. Amounts deferred under the plan (which includes dividend accruals on plan balances and may also include cash director fees) are converted into a particular number of notional shares of Danaher common stock, calculated based on the closing price of Danaher's common stock on the quarterly date such amounts otherwise would have been paid. The price shown in Table II, Column 8 above is the closing price per share of the Danaher common stock as reported on the NYSE on the transaction date noted above. Read SEC document |
| May 15, 2022 Filed May 17, 2022 21:19 UTC | DANAHER CORP /DE/ DHR · Entity 2871 | GrantDirector stock option (right to buy) · Derivative | 929 | $0.00 Strike: $249.19 | $0.00 |
DisclosureSEC source: 0000313616-22-000151 · wf-form4_165282233457815.xml · derivative · entry 3 Zerhouni Elias A. · CIK 0001478398 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 929 Underlying: Common Stock · 929 shares Expires 2032-05-15 Read SEC document |
| May 15, 2022 Filed May 17, 2022 21:19 UTC | DANAHER CORP /DE/ DHR · Entity 2871 | GrantCommon Stock | 372 | $0.00 | $0.00 |
DisclosureSEC source: 0000313616-22-000151 · wf-form4_165282233457815.xml · nonDerivative · entry 1 Zerhouni Elias A. · CIK 0001478398 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,836.524 F1 · shares: On the date indicated, Danaher Corporation granted the reporting person restricted stock units (RSUs) in the amount indicated. Since the RSUs are payable solely in common stock, they are being reported in Table I of this Form 4. The RSUs vest on the earlier of the first anniversary of the grant date, or the date of (and immediately prior to) the next annual meeting of Danaher's shareholders following the grant date, but the underlying shares are not issued until the earlier of the director's death or the first day of the seventh month following the director's retirement from the Board. Read SEC document |
| May 10, 2022 Filed May 12, 2022 01:01 UTC | OPKO HEALTH, INC. OPK · Entity 4891 | PurchaseCommon Stock | 89,600 | $2.79 | $250,396.16 |
DisclosureSEC source: 0001209191-22-028425 · doc4.xml · nonDerivative · entry 1 Zerhouni Elias A. · CIK 0001478398 · Director · Vice Chairman and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 89,600 Read SEC document |
| May 09, 2022 Filed May 12, 2022 01:01 UTC | OPKO HEALTH, INC. OPK · Entity 4891 | GrantStock Option (Right to Buy) · Derivative | 34,923 | $0.00 Strike: $3.20 | $0.00 |
DisclosureSEC source: 0001209191-22-028425 · doc4.xml · derivative · entry 2 Zerhouni Elias A. · CIK 0001478398 · Director · Vice Chairman and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,923 Underlying: Common Stock · 34,923 shares Expires 2032-05-08 F1 · derivative.exercise_date: This option will vest in four equal annual installments beginning May 9, 2023. Read SEC document |
| May 09, 2022 Filed Jun 22, 2022 20:42 UTC Amendment | OPKO HEALTH, INC. OPK · Entity 4891 | GrantCommon Stock | 19,777,514 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-22-038693 · doc4a.xml · nonDerivative · entry 2 Zerhouni Elias A. · CIK 0001478398 · Director · Vice Chairman and President 10b5-1 filing: Not disclosed Ownership: Indirect · Held by the EAZ ZERAZ TRUST Disclosed balance after: 19,777,514 F1 · date: This Form 4 amendment is being filed to report the acquisition of shares of the Issuer's common stock by the ZERHOUNI IRREVOCABLE TRUST and the EAZ ZERAZ TRUST, in each case, pursuant to the ModeX Merger (as defined below), inadvertently omitted in the original Form 4. F4 · price: Received in exchange for 2,250,000 shares of ModeX held directly by the EAZ ZERAZ TRUST in connection with the ModeX Merger. F5 · ownership.nature: Shares held by the EAZ ZERAZ TRUST for the benefit of the Reporting Person's spouse and children and remoter issue, as well as certain qualifying charitable organizations, and for which an independent trustee has been appointed. The Reporting Person disclaims beneficial ownership of these securities, except to the extent of any pecuniary interest therein and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Read SEC document |
| May 09, 2022 Filed Jun 22, 2022 20:42 UTC Amendment | OPKO HEALTH, INC. OPK · Entity 4891 | GrantCommon Stock | 19,777,514 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-22-038693 · doc4a.xml · nonDerivative · entry 1 Zerhouni Elias A. · CIK 0001478398 · Director · Vice Chairman and President 10b5-1 filing: Not disclosed Ownership: Indirect · Held by the ZERHOUNI IRREVOCABLE TRUST Disclosed balance after: 19,777,514 F1 · date: This Form 4 amendment is being filed to report the acquisition of shares of the Issuer's common stock by the ZERHOUNI IRREVOCABLE TRUST and the EAZ ZERAZ TRUST, in each case, pursuant to the ModeX Merger (as defined below), inadvertently omitted in the original Form 4. F2 · price: Received in exchange for 2,250,000 shares of ModeX Therapeutics, Inc., a Delaware corporation ("ModeX"), held directly by the ZERHOUNI IRREVOCABLE TRUST in connection with the Agreement and Plan of Merger, dated as of May 9, 2022, by and among the Issuer, ModeX, Orca Acquisition Sub, Inc., a Delaware corporation and wholly owned subsidiary of the Issuer, and Gary J. Nabel, solely in his capacity as sellers' representative, pursuant to which ModeX became a wholly owned subsidiary of the Issuer (the "ModeX Merger"). F3 · ownership.nature: Shares held by the ZERHOUNI IRREVOCABLE TRUST for the benefit of the Reporting Person and his children and remoter issue, as well as certain qualifying charitable organizations, and for which an independent trustee has been appointed. The independent trustee has delegated investment authority of the trust to the Reporting Person. The Reporting Person disclaims beneficial ownership of these securities, except to the extent of any pecuniary interest therein and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.